Recombinant activated factor VIIa in a case of pregnancy with acute hepatic failure and massive blood loss.
作者信息
Singh Shivinder, Menon Aruna, Thareja Sandeep
机构信息
Associate Professor, Department of Anaesthesiology, AFMC, Pune - 40.
Senior Advisor (Obstetrics & Gynaecology), Command Hospital (WC), Chandimandir, Panchkula, Haryana.
出版信息
Med J Armed Forces India. 2011 Oct;67(4):390-3. doi: 10.1016/S0377-1237(11)60096-8. Epub 2011 Oct 22.
Abstract
摘要
相似文献
1
Recombinant activated factor VIIa in a case of pregnancy with acute hepatic failure and massive blood loss.重组活化凝血因子VIIa治疗一例合并急性肝衰竭及大量失血的妊娠患者
Med J Armed Forces India. 2011 Oct;67(4):390-3. doi: 10.1016/S0377-1237(11)60096-8. Epub 2011 Oct 22.
2
Recombinant activated factor VIIa in case of pregnancy with acute hepatic failure and massive blood loss.重组活化凝血因子VIIa用于妊娠合并急性肝衰竭及大量失血的情况。
Med J Armed Forces India. 2012 Jan;68(1):96. doi: 10.1016/S0377-1237(11)60146-9.
3
Recombinant activated factor VIIa in case of pregnancy with acute hepatic failure and massive blood loss: Reply.重组活化凝血因子VIIa用于妊娠合并急性肝衰竭及大量失血的情况：回复
Med J Armed Forces India. 2012 Jan;68(1):96. doi: 10.1016/S0377-1237(12)60013-6.
4
Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.重组活化凝血因子VIIa用于控制出血：非血友病患者的止血实验室研究
Blood Coagul Fibrinolysis. 2006 Jun;17(4):241-9. doi: 10.1097/01.mbc.0000224842.25592.8a.
5
Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.重组凝血因子VIIa用于心脏手术后难治性失血：倾向评分匹配的病例对照分析
Transfusion. 2005 Jan;45(1):26-34. doi: 10.1111/j.1537-2995.2005.04216.x.
6
Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.重组凝血因子VIIa成功治疗羊水栓塞所致的弥散性血管内凝血。
Obstet Gynecol. 2007 Feb;109(2 Pt2):524-5. doi: 10.1097/01.AOG.0000235711.11817.8c.
7
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.重组活化凝血因子VII对耻骨后前列腺切除术患者围手术期失血的影响：一项双盲安慰剂对照随机试验。
Lancet. 2003 Jan 18;361(9353):201-5. doi: 10.1016/S0140-6736(03)12268-4.
8
Recombinant factor VIIa for intraoperative bleeding in a child with hepatoblastoma and review of recombinant activated factor VIIa use in children undergoing surgery.
J Pediatr Surg. 2008 Apr;43(4):e15-9. doi: 10.1016/j.jpedsurg.2008.01.002.
9
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.重组凝血因子VIIa治疗严重出血的疗效与安全性：一项系统评价
Crit Care Med. 2005 Apr;33(4):883-90. doi: 10.1097/01.ccm.0000159087.85970.38.
10
Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.大量产后出血：使用重组凝血因子VIIa安全但无效。
Del Med J. 2011 Apr;83(4):109-13.
引用本文的文献
1
Key Components of Successful Management of Acute Fatty Liver of Pregnancy: A Case Report and Literature Review.妊娠急性脂肪肝成功管理的关键要素：一例病例报告及文献综述
Cureus. 2024 Feb 9;16(2):e53911. doi: 10.7759/cureus.53911. eCollection 2024 Feb.
2
Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders.使用重组活化因子VII控制妊娠急性脂肪肝及其他妊娠相关肝脏疾病产后出血的初步经验。
Indian J Gastroenterol. 2013 Jul;32(4):268-71. doi: 10.1007/s12664-013-0315-4. Epub 2013 Mar 10.
本文引用的文献
1
The use of recombinant activated FVII in postpartum hemorrhage.重组活化凝血因子VII在产后出血中的应用。
Clin Obstet Gynecol. 2010 Mar;53(1):219-27. doi: 10.1097/GRF.0b013e3181cc4378.
2
Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.大量产科出血中重组活化凝血因子VII的使用指南。
Aust N Z J Obstet Gynaecol. 2008 Feb;48(1):12-6. doi: 10.1111/j.1479-828X.2007.00823.x.
3
Use of recombinant activated factor VII in massive postpartum haemorrhage.重组活化凝血因子 VII 在产后大出血中的应用。
Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):172-7. doi: 10.1016/j.ejogrb.2007.06.022. Epub 2007 Oct 24.
4
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.关于使用重组活化凝血因子VII作为大出血辅助治疗的建议——欧洲视角
Crit Care. 2006;10(4):R120. doi: 10.1186/cc5026.
5
Therapeutic approaches in trauma-induced coagulopathy.创伤性凝血病的治疗方法。
Minerva Anestesiol. 2005 Jun;71(6):281-9.
6
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.重组活化凝血因子 VII（rFVIIa）用于控制出血的指南：以色列多学科 rFVIIa 工作组报告
J Thromb Haemost. 2005 Apr;3(4):640-8. doi: 10.1111/j.1538-7836.2005.01203.x.
7
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.重组凝血因子VIIa治疗严重出血的疗效与安全性：一项系统评价
Crit Care Med. 2005 Apr;33(4):883-90. doi: 10.1097/01.ccm.0000159087.85970.38.
8
Recombinant factor VIIa for life-threatening post-partum haemorrhage.重组凝血因子VIIa用于治疗危及生命的产后出血。
Br J Anaesth. 2005 May;94(5):592-5. doi: 10.1093/bja/aei094. Epub 2005 Feb 11.
9
Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.
BJOG. 2004 Mar;111(3):284-7. doi: 10.1111/j.1471-0528.2004.00058.x.
10
Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy.活化重组人凝血因子VII（rhFVIIa）在肝硬化和凝血病患者结肠息肉切除术中的应用。
Dig Dis Sci. 2003 Jul;48(7):1414-24. doi: 10.1023/a:1024144217614.
Zotero 插件